Aurora Cannabis Inc. (ACB)

Marijuana stocks have begun to gain traction in trading, exhibiting moderate consistency. But why did this occur, and what is happening to bring such momentum to the sector? Once again, the backing an...

Cannabis stocks moved sharply higher on reports that President Donald Trump is considering rescheduling marijuana to a less restrictive drug category. The move would see marijuana reclassified from a ...

Aurora Cannabis reported mixed Q1 FY2026 results, with core medical cannabis sales pressured by regulatory changes and competition. In addition, the company's plant propagation subsidiary experienced ...

Aurora Cannabis stock slips after Q1 earnings miss, but revenue climbs 17.5% year over year on strong global medical cannabis demand.

Aurora Cannabis Inc. (NASDAQ:ACB ) Q1 2026 Earnings Conference Call August 6, 2025 8:00 AM ET Company Participants Kevin Niland - Corporate Participant Miguel Martin - CEO & Executive Chairman Simona ...

Aurora Cannabis Inc. (ACB) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of $0.18. This compares to a loss of $0.11 per share a year ago.

ACB's global medical cannabis momentum stays strong, but near-term regulatory headwinds might have limited Q1 revenue upside.

Currently, the cannabis industry is in another transitional period, presenting both challenges and potential opportunities for investors. After several years of volatility and downward trading, mariju...

This moment in time for marijuana stock investors could be the best opportunity. Legal cannabis is a volatile sector where MSO and ancillary companies are dominating it. Even with a drop in value for ...

2025 has been a troubled time for marijuana stock investors. With a lack of momentum and no sign of any upward trading, what are shareholders to do? Now, the cannabis industry outside of the public se...